Antihypertensive drug treatment in a Swedish community: Skaraborg hypertension and diabetes project

Pharmacoepidemiology and Drug Safety

Volumn 11, Issue 1, 2002, Pages 45-54

  Bøg Hansen, Erik ^a,b   Lindblad, Ulf ^a,c   Ranstam, Jonas ^d   Melander, Arne ^a,e   Råstam, Lennart ^a,f  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Skara Health Care Centre   (Sweden)

^c Skaraborgs Institutet   (Sweden)

^d MALMÖ UNIVERSITY   (Sweden)

^e Network for Pharmacoepidemiology Foundation   (Sweden)

^f National Public Health Institute   (Sweden)

Author keywords

Hypertension; Pharmacological treatment; Primary health care

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMILORIDE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; LOOP DIURETIC AGENT; METHYLDOPA; POTASSIUM; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ADULT; AGED; ARTICLE; COMMUNITY; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG USE; ECONOMIC ASPECT; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRESCRIPTION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SEX DIFFERENCE; SIDE EFFECT; SWEDEN; TIME;

ADRENERGIC BETA-ANTAGONISTS; AGE DISTRIBUTION; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DIABETES MELLITUS; DIURETICS; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; HYPERTENSION; MALE; NATIONAL HEALTH PROGRAMS; SEX DISTRIBUTION; SWEDEN;

EID: 0036208687     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.681     Document Type: Article

References (38)

1. The Australian therapeutic trial in mild hypertension
2. MRC trial of treatment of mild hypertension: Principal results
3. Five-year findings of the Hypertension Detection and Follow-up Program
4. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
5. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
6. Antihypertensive therapy and lipids
7. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism
8. Information från Socialstyrelsens läkemedelsavdelning
9. Calcium channel blockers
10. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS)
11. The risk of myocardial infarction associated with antihypertensive drug therapies
12. Use of calcium channel blockers and risk of suicide: Ecological findings confirmed in population based cohort study
13. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM
14. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
15. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 Study
16. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in treated hypertension: The Captopril Prevention Project (CAPPP)
17. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
18. Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study
19. The Skaraborg Project- a controlled trial regarding the effect of structured hypertension care
20. Vårdprogram för högt blodtryck i Skaraborgs län
21. (National guidelines for treatment of hypertension in elderly people)
22. Risk factor clustering in patients with hypertension and non-insulin-dependent diabetes mellitus
23. Trends in the use of blood pressure lowering medications in Auckland, and associated costs, 1982-94
24. Trends in pharmacologic management of hypertension in the United States
25. Antihypertensive drug therapy. The effect of JNC criteria on prescribing patterns and patient status through the first year
26. Evaluation, and Treatment of High Blood Pressure (JNC-V)
27. Trends in medication choices for hypertension in the elderly. The decline of the thiazides
28. Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study
29. Contemporary practice patterns in the management of newly diagnosed hypertension
30. Trends in antihypertensive drug advertising, 1985-1996
31. Who is using antihypertensive drugs?
32. Drug treatment for hypertension in Finnish primary health care
33. Antihypertensive drug prescribing in The Netherlands
34. Sex differences in antihypertensive drug use: Determinants of the choice of medication for hypertension
35. Effect of salt on insulin sensitivity differs according to gender and degree of salt sensitivity
36. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: Results of the HANE study
37. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension